Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

HPV testing in cervical screening.

Antoinette A T P Brink¹, Peter J F Snijders, Chris J L M Meijer

¹Department of Pathology, VU University Medical Center, P.O. Box 7057,1007 MB Amsterdam, The Netherlands.

Best Practice & Research. Clinical Obstetrics & Gynaecology

|December 20, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Triage Performance of FAM19A4/miR124-2 Methylation: 18-Month Follow-Up Results From a Prospective Observational Study Within the Dutch Primary HPV-Based Cervical Screening Program.

International journal of cancer·2026

Same author

Aberrant intra-epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103-β7-receptor-mediated granzyme-B degranulation which can be restored by etrolizumab.

Clinical & translational immunology·2026

Same author

Clinical performance of ASCL1/LHX8 DNA methylation on first-void urine to screen for cervical cancer.

Communications medicine·2026

Same author

Diagnostic characteristics of the Rapid ESBL NP<sup>®</sup> test and ResistanceFinder 2SMART multiplex PCR for the detection of ESBL directly on urine samples.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025

Same author

Molecular Insights Into the Natural History of Anal HSIL.

Journal of medical virology·2025

Same author

Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation and/or HPV genotyping in HPV positive women with low-grade cytology from a population-based Dutch primary HPV screening trial.

International journal of cancer·2024

High-risk human papillomavirus (hrHPV) testing aids cervical cancer screening and monitoring. HPV genotyping, especially for HPV types 16 and 18, is crucial for assessing high-grade lesions and guiding treatment decisions.

Area of Science:

Gynecology
Oncology
Virology

Background:

Cervical intraepithelial neoplasia (CIN) is a precursor to cervical cancer, driven by persistent high-risk human papillomavirus (hrHPV) infections.
hrHPV testing is valuable for population-based screening and monitoring therapy efficacy for high-grade CIN.
Accurate hrHPV test specificity data is essential for considering its replacement of cytology in screening programs.

Purpose of the Study:

To evaluate the role of hrHPV testing in cervical cancer screening and management.
To explore additional testing methods for stratifying hrHPV-positive women.
To highlight the importance of HPV genotyping for risk assessment.

Main Methods:

Review of hrHPV testing as an adjunct to cervical cytology.

Related Experiment Videos

Discussion of HPV genotyping, viral load analysis, and hrHPV mRNA analysis for risk stratification.

Case illustration of HPV genotyping for HPV types 16 and 18.

Main Results:

hrHPV testing is a valuable adjunct to cytology and for monitoring therapy.
HPV genotyping identifies increased risk for high-grade lesions, particularly with HPV 16 and 18.
Persistent HPV18 positivity in normal smears warrants further investigation due to association with glandular lesions.

Conclusions:

hrHPV testing plays a key role in cervical cancer prevention and management.
HPV genotyping is essential for accurate risk stratification and clinical decision-making.
Further research on hrHPV test specificity is needed for potential cytology replacement.